Page 21 - Serum Institute Of India
Expert panel set to review Pfizer-BioNTech, SII vaccine applications today
ICMR Director General Balram Bhargava said that in the case of temporary licensure or emergency use, the regulator had to be satisfied with the risk-benefit ratio.
 "Expert panel set to review Pfizer-BioNTech, SII vaccine applications today")
Coronavirus LIVE: Covid-19 situation in Delhi stabilising, says NITI Aayog
Coronavirus live updates: At 18,55,341, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 894,004, Andhra Pradesh 872,288, Tamil Nadu 791,552, and Kerala 639,664
Pfizer, Serum or Bharat Biotech - whose Covid vaccine will be India's 1st?
In this podcast, we will talk about the Covid Vaccine scenario, in which we will discuss trial results, efficacy among other things
 "Pfizer, Serum or Bharat Biotech - whose Covid vaccine will be India's 1st?")
Serum set for deal with Centre soon; to supply vaccine at Rs 250 a dose
There is still time before SII can start supplying to the low and medium income countries through Gavi
 "Serum set for deal with Centre soon; to supply vaccine at Rs 250 a dose")
Decoded: What emergency use authorisation of Covid vaccine means for us
After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation
 "Decoded: What emergency use authorisation of Covid vaccine means for us")
India weighing quick emergency review of Pfizer, AstraZeneca vaccines
Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.
 "India weighing quick emergency review of Pfizer, AstraZeneca vaccines")
Serum seeks emergency use nod for Oxford's Covid-19 vaccine in India
According to the ICMR, the SII has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license it obtained from the DCGI
 "Serum seeks emergency use nod for Oxford's Covid-19 vaccine in India")
DCGI reassures all protocols being followed in Serum's clinical trials
The ethics committee has seven members, including a chairperson who has to be from outside the institution where the trial is being conducted.
 "DCGI reassures all protocols being followed in Serum's clinical trials")
DCGI finds no link between Covid vaccine shot, 'adverse' reaction: Report
The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer
 "DCGI finds no link between Covid vaccine shot, 'adverse' reaction: Report")
Adverse event in Serum's trial won't affect vaccine timelines: Health secy
Health ministry to come out with guidelines that will address the issues around vaccine safety to create awareness and dispel misinformation
 "Adverse event in Serum's trial won't affect vaccine timelines: Health secy")
AstraZeneca partner sticks with 2 full dose regimen in India Covid trials
The British drugmaker has said its COVID-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose
 "AstraZeneca partner sticks with 2 full dose regimen in India Covid trials")
Findings into 'adverse event' at Serum didn't require halting trial: Govt
The Pune-based vaccine manufacturer on Tuesday said that the vaccine is safe and immunogenic
 "Findings into 'adverse event' at Serum didn't require halting trial: Govt")
India Coronavirus Dispatch: How emergency vaccine authorisation works
Queues at Ahmedabad's crematoriums get longer, doubts about AstraZeneca vaccine and bringing diagnostics closer to communities-news relevant to India's fight against Covid-19
 "India Coronavirus Dispatch: How emergency vaccine authorisation works")
Coronavirus vaccine update: Serum vs volunteer fight, PM calls meet, & more
Listen to the podcast to know all the key updates related to vaccine
 "Coronavirus vaccine update: Serum vs volunteer fight, PM calls meet, & more")
Covishield's approval process hinges on adverse event investigation
SII has in response stated that the allegations made in the legal notice are 'malicious and misconceived', and that it will seek damages in excess of Rs 100 crore.
Inform people about vaccine in simple language, PM tells manufacturers
Serum Institute in Pune will undertake mass production of Covishield vaccine developed by Oxford-Astra Zeneca
 "Inform people about vaccine in simple language, PM tells manufacturers")
Ambassadors of 100 countries to visit Serum Institute, Gennova Biopharma
Sweden seeks to expand ties with India in health and life sciences, Luxembourg-based firm B Systems is partnering with India to produce portable vaccine refrigeration equipment
 "Who will get Covid vaccine first? Serum CEO on distribution, pricing & Modi")
Top headlines: Tata sons to raise stake in AirAsia; Serum seeks damages
From Tata Sons raising stakes in AirAsia to putting off artillery import embargo, here are top headlines this morning
 "Top headlines: Tata sons to raise stake in AirAsia; Serum seeks damages")
Serum Institute seeks Rs 100 cr in damages from trial subject
Experts feel trust is broken as trial was not halted; Chennai resident had sought Rs 5 cr in compensation
 "Serum Institute seeks Rs 100 cr in damages from trial subject")
